BioSpace News Archive

This is the second extension that has been filed, this time delaying it until June 3. The companies indicate it is because U.S. authorities are taking longer than expected to review the deal.

Bausch Health, former known as Valeant Pharmaceuticals International, announced that the U.S. Food and Drug Administration (FDA) had approved its Duobrii (halobetasol propionate and tazoretene) Lotion for plaque psoriasis.

AstraZeneca reported first-quarter financials, with Product Sales growing 10% (14% at CER) to $5.465 billion. What is more startling, and completely in accordance with the company’s stated goals, Global Oncology sales increased by 54%.

In September 2018 a leap forward in treating burn victims was made with the approval of Avita Medical’s RECELL Autologous Cell Harvesting Device. The Food and Drug Administration (FDA) green lit the California-based company’s burn treatment device that uses a small amount of a patient’s own skin to prepare what is called Spray-On Skin Cells.

This week has a number of approvals expected by the U.S. Food and Drug Administration. Let’s take a look.

We had the opportunity to meet with Arti Dumbrepatil, a postdoctoral fellow in the University of Michigan’s chemistry department. Arti explained her journey as an international student and how a postdoctoral fellowship can prepare you for a career as an independent scientist!

Preparations for Upcoming Clinical Data in the MERECA and GIST Studies and First Patient Treated in the ILIAD Study

Bringing Attention to Malaria Vaccine Development Efforts

Aqilion searches for early innovative pharmaceutical projects that are based on solid research resting on a firm biological foundation and offering both clinical relevance and patient benefit.

Conference call to be held today, 25 April 2019, 3:00pm CET/2:00pm BST